Interactions of α-melanotropin and agouti on B16 melanoma cells: Evidence for inverse agonism of agouti

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 1-3, 1997, Pages 75-98

  Siegrist, Walter ^a   Drozdz, Roma ^a   Cotti, Renato ^a   Willard, Derril H ^b   Wilkison, William O ^b   Eberle, Alex N ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CHOLERA TOXIN; FORSKOLIN; MELANIN; PERTUSSIS TOXIN;

ANIMAL CELL; CELL PROLIFERATION; CONFERENCE PAPER; GROWTH INHIBITION; MALIGNANT TRANSFORMATION; MELANOGENESIS; MELANOMA CELL; MOUSE; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0031017205     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036595     Document Type: Conference Paper

References (47)

1. Koh, H.K. Cutaneous melanoma. N. Engl. J. Med. 325, 171-182, 1991.
2. Rodeck, U.; and Herlyn, M. Growth factors in melanoma. Cancer Metastasis Rev. 10, 89-101, 1991.
3. Jackson, I.J. Molecular genetics. Colour-coded switches. Nature 362, 587-588, 1993.
4. Prota, G. Melanins and Melanogenesis, Academic Press, New York, 1992.
5. Chhajlani, V.; and Wikberg, J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417-420, 1992.
6. Mountjoy, K.G.; Robbins, L.S.; Mortrud, M.T.; and Cone, R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251, 1992.
7. Robbins, L.S.; Nadeau, J.H.; Johnson, K.R.; Kelly, M.A.; Roselli-Rehfuss, L.; Baack, E.; Mountjoy, K.G.; and Cone, R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834, 1993.
8. Eberle, A.N. The Melanotropins: Chemistry, Physiology and Mechanisms of Action, Karger, Basel, 1988.
9. Abdel-Malek, Z.A.; Hadley, M.E.; Bregman, M.D.; Meyskens, F., Jr.; and Hruby, V.J. Actions of melanotropins on mouse melanoma cell growth in vitro. J. Natl. Cancer Inst. 76, 857-863, 1986.
10. Bregman, M.D.; Abdel-Malek, Z.A.; and Meyskens, F., Jr. Anchorage-independent growth of murine melanoma in serumless media is dependent on insulin or melanocyte-stimulating hormone. Exp. Cell Res. 157, 419-428, 1985.
11. Slominski, A.; Moellmann, G.; and Kuklinska, E. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis. J. Cell Sci. 92, 551-559, 1989.
12. Wick, M.M. Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline. J. Invest. Dermatol. 77, 253-255, 1981.
13. Bultman, S.J.; Michaud, E.J.; and Woychik, R.P. Molecular characterization of the mouse agouti locus. Cell 71, 1195-1204, 1992.
14. Lu, D.; Willard, D.; Patel, I.R.; Kadwell, S.; Overton, L.; Kost, T.; Luther, M.; Chen, W.; Woychik, R.P.; Wilkison, W.O.; and Cone, R.D. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802, 1994.
15. Willard, D.H.; Bodnar, W.; Harris, C.; Kiefer, L.; Nichols, J.S.; Blanchard, S.; Hoffman, C.; Moyer, M.; Burkhart, W.; Weiel, J.; Luther, M.A.; Wilkison, W.O.; and Rocque, W.J. Agouti structure and function: Characterization of a potent α-melanocyte-stimulating hormone receptor antagonist. Biochemistry 34, 12341-12346, 1995.
16. Yen, T.T.; Gill, A.M.; Frigeri, L.G.; Barsh, G.S.; and Wolff, G.L. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J. 8, 479-488, 1994.
17. Zemel, M.B.; Kim, J.H.; Woychik, R.P.; Michaud, E.J.; Kadwell, S.H.; Patel, I.R.; and Wilkison, W.O. Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 92, 4733-4737, 1995.
18. Manne, J.; Argeson, A.C.; and Siracusa, L.D. Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl. Acad. Sci. USA 92, 4721-4724, 1995.
19. Black, J.W.; and Shankley, N.P. Drug receptors. Inverse agonists exposed. Nature 374, 214-215, 1995.
20. Milligan, G.; Bond, R.A.; and Lee, M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16, 10-13, 1995.
21. Schutz, W.; and Freissmuth, M. Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 13, 376-380, 1992.
22. 2-adrenoceptor. Nature 374, 272-276, 1995.
23. Siegrist, W.; Willard, D.H.; Wilkison, W.O.; and Eberle, A.N. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors. Biochem. Biophys. Res. Commun. 218, 171-175, 1996.
24. Summers, M.D.; and Smith, G.E. A manual of methods for baculovirus vectors and insect cell-culture procedures. Texas Agric. Exp. St. Bull. 1555, 1987.
25. Fidler, I.J. Selection of successive tumour lines for metastasis. Nature New Biol. 242, 148-149, 1973.
26. Solca, F.F.; Chluba-de-Tapia, J.; Iwata, K.; and Eberle, A.N. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone. FEBS Lett. 322, 177-180, 1993.
27. Oliver, M.H.; Harrison, N.K.; Bishop, J.E.; Cole, P.J.; and Laurent, G.J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92, 513-518, 1989.
28. Siegrist W.; and Eberle, A.N. In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Anal. Biochem. 159, 191-197, 1986.
29. Eberle, A.N.; Jäggin Verin, V.J.; Solca, F.; Siegrist, W.; Kuenlin, C.; Bagutti C.; Stutz, S.; and Girard, J. Biologically active monoiodinated α-MSH derivatives for receptor binding studies using human melanoma cells. J. Recept. Res. 11, 311-322, 1991.
30. Siegrist, W.; Solca, F.; Stutz, S.; Giuffre, L.; Carrel, S.; Girard, J.; and Eberle, A.N. Characterization of receptors for α-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 49, 6352-6358, 1989.
31. Munson, P.J.; and Rodbard, D. Ligand; a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239, 1980.
32. Gerst J.E.; Sole, J.; Mather, J.P.; and Salomon, Y. Regulation of adenylate cyclase by β-melanotropin in the M2R melanoma cell line. Mol. Cell. Endocrinol. 46, 137-147, 1986.
33. Lester, B.R.; McCarthy, J.B.; Sun, Z.Q.; Smith, R.S.; Furcht, L.T.; and Spiegel, A.M. G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones. Cancer Res. 49, 5940-5948, 1989.
34. Siegrist, W.; Stutz, S.; and Eberle, A.N. Homologous and heterologous regulation of α-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 54, 2604-2610, 1994.
35. Siegrist W.; and Eberle, A.N. Homologous regulation of the MSH receptor in melanoma cells. J. Receptor Res. 13, 263-281, 1993.
36. Siegrist, W.; Oestreicher, M.; Stutz, S.; Girard, J.; and Eberle, A.N. Radioreceptor assay for a-MSH using mouse B16 melanoma cells. J. Receptor Res. 8, 323-343, 1988.
37. Laurenza, A.; Sutkowski, E.M.; and Seamon, K.B. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol. Sci. 10, 442-447, 1989.
38. Birnbaumer, L.; and Birnbaumer, M. Signal transduction by G proteins: 1994 edition. J. Receptor Signal Transduction Res. 15, 213-252, 1995.
39. Konda, Y.; Gantz, I.; DelValle, J.; Shimoto, Y.; Miwa, H.; and Yamada, T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166, 1994.
40. De Luca, M.; Siegrist, W.; Bondanza, S., Mathor, M.; Cancedda, R.; and Eberle, A.N. αMelanocyte stimulating hormone (αMSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J. Cell Sci. 105, 1079-1084, 1993.
41. Yaar, M.; and Gilchrest, B.A. Human melanocyte growth and differentiation: a decade of new data. J. Invest. Dermatol. 97, 611-617, 1991.
42. Pawelek, J.; Körner, A.; Bergstrom, A.; and Bologna, J. New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 286, 617-619, 1980.
43. De Blasi, A.; Parruti, G.; and Sallese, M. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2. J. Clin. Invest. 95, 203-210, 1995.
44. Conklin, B.R.; and Bourne, H.R. Mouse coat colour reconsidered, Nature 364, 110, 1993.
45. Kobayashi, T.; Vieira, W.D.; Potterf, B.; Sakai, C.; Imokawa, G.; and Hearing, V.J. Modulation of melanogenic protein expression during switch from eu-to pheomelanogenesis. J. Cell Sci. 108, 2301-2309, 1995.
46. Gantz, I.; Shimoto, Y.; Konda, Y.; Miwa, H.; Dickinson, C.J.; and Yamada, T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1214-1220, 1994.
47. Labbe, O.; Desarnaud, F.; Eggerickx, D.; Vassart, G.; and Parmentier, M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33, 4543-4549, 1994.